Titan Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $10 | $0 |
Gross Profit | 5 | |||
EBITDA | -657 | -534 | -666 | |
EBIT | -657 | -534 | -661 | -754 |
Net Income | -689 | -563 | -790 | -763 |
Net Change In Cash | 0 | 0 | 10 | 0 |
Free Cash Flow | -680 | -867 | -506 | -693 |
Cash | 2,803 | 1,945 | 2,831 | 3,399 |
Basic Shares | 1,065 | 914 | 899 | 914 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1 | $60 | $1,526 |
Gross Profit | -5 | 1 | -136 | 1,327 |
EBITDA | -4,701 | -7,165 | -10,039 | -9,133 |
EBIT | -4,706 | -7,277 | -10,235 | -9,354 |
Net Income | -4,706 | -5,569 | -10,177 | -8,114 |
Net Change In Cash | 0 | 1 | 60 | 1,526 |
Free Cash Flow | -3,880 | -7,094 | -8,183 | -7,922 |
Cash | 2,831 | 6,760 | 2,937 | 6,037 |
Basic Shares | 899 | 752 | 671 | 1,997 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.65 |
2025-03-31 | -$0.62 |
2024-12-31 | -$0.86 |
2024-09-30 | -$0.83 |
